Similarly, cryptotanshinone is also considered an effective drug for the treatment of pulmonary fibrosis because it can regulate the TGF-β1/Smad3, STAT3 and SIRT3 signaling pathways (Wang et al., 2022). This evidence concerns the gene SIRT3 and pulmonary fibrosis.